CatalystFDA/Bio

Pfizer-backed Priovant wins FDA approval for lead asset

FDA approval validates Priovant's lead asset, backed by Pfizer.

What changed

Why it matters

FDA approval validates Priovant's lead asset, backed by Pfizer.

Sources